Get started
Author

Julie K. Spence

Observed name: Julie Spence
OpenAlex ID: A5113592698
A Win–Win Solution in Oral Delivery of Lipophilic Drugs: Supersaturation via Amorphous Solid Dispersions Increases Apparent Solubility without Sacrifice of Intestinal Membrane Permeability
2012 · Jonathan M. Miller, Avital Beig, et al. · Molecular Pharmaceutics · 262
The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia
2015 · William N. Pappano, Jun Guo, et al. · PLoS ONE · 100
PDF
A pH-Dilution Method for Estimation of Biorelevant Drug Solubility along the Gastrointestinal Tract: Application to Physiologically Based Pharmacokinetic Modeling
2010 · Yi Gao, Robert A. Carr, et al. · Molecular Pharmaceutics · 74
Comparison of artificial sebum with human and hamster sebum samples
2008 · Guang Wei Lu, Satyanarayana Valiveti, et al. · International Journal of Pharmaceutics · 63
Increased Dissolution Rate and Bioavailability Through Comicronization with Microcrystalline Cellulose
2005 · Julie K. Spence, Shobha N. Bhattachar, et al. · Pharmaceutical Development and Technology · 22
Rational Design of a Topical Androgen Receptor Antagonist for the Suppression of Sebum Production with Properties Suitable for Follicular Delivery
2010 · Lorna H. Mitchell, Theodore R. Johnson, et al. · Journal of Medicinal Chemistry · 13
Synthesis of the Potassium Channel Opener (3S,4R)‐3,4‐Dihydro‐4‐(2,3‐dihydro‐2‐methyl‐3‐oxo‐pyridazin‐6‐Yl)oxy‐3‐hydroxy‐6‐(3‐hydroxyphenyl)sulphonyl‐2,2,3‐trimethyl‐2H‐benzo[b]pyran
2007 · Javier Magano, Allison Acciacca, et al. · Synthetic Communications · 3
ChemInform Abstract: Synthesis of the Potassium Channel Opener (3S,4R)‐3,4‐Dihydro‐4‐ (2,3‐dihydro‐2‐methyl‐3‐oxo‐pyridazin‐6‐yl)oxy‐3‐hydroxy‐6‐ (3‐hydroxyphenyl)sulfonyl‐2,2,3‐trimethyl‐2H‐benzo[b]pyran.
2008 · Javier Magano, Allison Acciacca, et al. · ChemInform
Works count: 8
Citation count: 537
H-index: 6
I10-index: 6
Year
Topic
Type